ABCA1 and ovarian serous adenocarcinoma: Our study found that high ABCA1 mRNA and protein expression was significantly associated with poor clinical outcome and increased in ovarian cancer cell lines and primary serous ovarian cancer cells following acquired chemotherapy resistance.